2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid

C31H29FN6O6S — CID 59204648

IUPAC2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid
SMILESO=C(O)CN1CC(=O)N2[C@@H](Cc3ccc(O)cc3)C(=O)N(Cc3ccc(F)c4scnc34)C[C@@H]2N1C(=O)NCc1ccccc1
InChIInChI=1S/C31H29FN6O6S/c32-23-11-8-21(28-29(23)45-18-34-28)14-35-15-25-37(24(30(35)43)12-19-6-9-22(39)10-7-19)26(40)16-36(17-27(41)42)38(25)31(44)33-13-20-4-2-1-3-5-20/h1-11,18,24-25,39H,12-17H2,(H,33,44)(H,41,42)/t24-,25-/m0/s1
InChIKeyNGWKKMOPALDXAD-DQEYMECFSA-N
MW632.67 g/mol
LogP2.78
Rot. Bonds8

About 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid

2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid (PubChem CID 59204648) has the molecular formula C31H29FN6O6S and a molecular weight of 632.67 g/mol. Its IUPAC name is 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid.

Molecular Properties

Compound Name2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid
PubChem CID59204648
Molecular FormulaC31H29FN6O6S
Molecular Weight632.67 g/mol
Exact Mass632.19
IUPAC Name2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid
SMILESO=C(O)CN1CC(=O)N2[C@@H](Cc3ccc(O)cc3)C(=O)N(Cc3ccc(F)c4scnc34)C[C@@H]2N1C(=O)NCc1ccccc1
InChIInChI=1S/C31H29FN6O6S/c32-23-11-8-21(28-29(23)45-18-34-28)14-35-15-25-37(24(30(35)43)12-19-6-9-22(39)10-7-19)26(40)16-36(17-27(41)42)38(25)31(44)33-13-20-4-2-1-3-5-20/h1-11,18,24-25,39H,12-17H2,(H,33,44)(H,41,42)/t24-,25-/m0/s1
InChIKeyNGWKKMOPALDXAD-DQEYMECFSA-N
XLogP2.78
TPSA146.62 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500632.67
LogP ≤ 52.78
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid?
The IUPAC name of 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid (CID 59204648) is 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid.
What is the SMILES notation for 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid?
The canonical SMILES for 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid is O=C(O)CN1CC(=O)N2[C@@H](Cc3ccc(O)cc3)C(=O)N(Cc3ccc(F)c4scnc34)C[C@@H]2N1C(=O)NCc1ccccc1.
What is the InChIKey of 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid?
The InChIKey is NGWKKMOPALDXAD-DQEYMECFSA-N. The full InChI is InChI=1S/C31H29FN6O6S/c32-23-11-8-21(28-29(23)45-18-34-28)14-35-15-25-37(24(30(35)43)12-19-6-9-22(39)10-7-19)26(40)16-36(17-27(41)42)38(25)31(44)33-13-20-4-2-1-3-5-20/h1-11,18,24-25,39H,12-17H2,(H,33,44)(H,41,42)/t24-,25-/m0/s1.
What are the key properties of 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid?
2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid has a molecular weight of 632.67 g/mol, XLogP of 2.78, 8 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(6S,9aS)-1-(benzylcarbamoyl)-8-[(7-fluoro-1,3-benzothiazol-4-yl)methyl]-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-2-yl]acetic acid is sourced from PubChem (CID 59204648), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).